DarioHealth (DRIO) Hits New 1-Year Low at $0.68
DarioHealth Corp (NASDAQ:DRIO) hit a new 52-week low on Monday . The stock traded as low as $0.68 and last traded at $0.70, with a volume of 1300 shares traded. The stock had previously closed at $0.81.
DarioHealth (NASDAQ:DRIO) last released its quarterly earnings results on Tuesday, November 13th. The company reported ($0.17) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.18) by $0.01. The firm had revenue of $1.88 million during the quarter. DarioHealth had a negative return on equity of 386.47% and a negative net margin of 343.72%.
DarioHealth Company Profile (NASDAQ:DRIO)
DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device.
Featured Article: Swap
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.